Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AngioDynamics - ANGO -- Ignore unavailable to you. Want to Upgrade?

To: Jim P. who wrote (11)	7/24/2005 2:01:54 PM
From: radman33	Read Replies (1) \| Respond to of 45

Another great quarter for ANGO! AngioDynamics Fiscal Fourth Quarter Operating Profit up 31% on 23% Increase in Net Sales biz.yahoo.com Net sales for the fourth quarter of fiscal 2005 were $17.3 million, an increase of 23% over net sales of $14.1 million for the fourth quarter of fiscal 2004. The increase reflects strong growth from most of the Company's product lines. Sales of Vascular Access products grew 150%, with the Morpheus(TM) CT PICC, a new product introduced in fiscal 2005, accounting for most of the gains in this line. VenaCure(TM) product sales were up 33% over the 2004 quarter, while hemodialysis products and angiographic products grew 15% and 12%, respectively.